Effective November 1, 2023, there are revisions to the Change Healthcare InterQual criteria for the following:
- BRCA1 & BRCA2 in Hereditgary Cancer
- Hereditary Prostate Cancer
- Li-Fraumni Syndrome
- Multi Gene Panels for Hereditary Breast Cancer Syndrome
- Multi Gene Panels for Ovarian Cancer Syndrome
- Pharmacogenomic Testing in Breast Cancer
- Pharmacogenomic Testing in NSCLC